Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors
Recruiting now · Not applicable
Conditions studied: Breast Cancer Survivorship, Breast Cancer, Digital Health
In brief
The ultimate goal of this research and development is to develop personalized digital healthcare technologies and self-management strategies based on self-assessment results and evidence, for breast cancer survivors who require management and recovery from acute and chronic side effects related to various treatments (surgery, chemotherapy, radiation, hormone therapy, etc.). Additionally, the aim is to verify the clinical applicability and establish a service model to address the diverse unmet healthcare needs of breast cancer survivors.
Key facts
- Study ID
- NCT06729684
- Run by
- Samsung Medical Center
- People needed
- 72
- Starts
- 2024-11-13
- Expected to finish
- 2025-05-31
- Last updated by the study team
- 2024-12-11
Who can join
Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Individuals who have undergone surgery for Stage 1-2 breast cancer
- Individuals who have had a unilateral mastectomy
- Aged 18 years or older and under 65 years
- Possessing a smartphone with either an Android or iOS operating system
- Individuals who voluntarily decide to participate after receiving detailed information about the study and provide written consent
You may not qualify if…
- Individuals who have undergone mastectomy only and are not receiving chemotherapy, radiation, or hormone therapy
- Individuals with severe comorbidities (such as underlying diseases, neuromuscular disorders, cognitive or mental impairments, visual disabilities, etc.) that make it difficult to use the application or participate in the exercise intervention
- Discontinuation Criteria
- Individuals who undergo delayed breast reconstruction surgery during the study period
- Individuals who develop severe complications or experience cancer metastasis or recurrence in other organs during the study period, leading to a change in treatment
- Occurrence of a major illness unrelated to study participation
- Failure to comply with the instructions of the study physician
- Situations where the participant voluntarily withdraws from the study or becomes unable to continue participating
Where it is running
- Samsung Medical Center — Seoul, Republic of Korea, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.